High-resolution photoionization spectrum of water molecules in a supersonic beam von PAGE, R. H, LARKIN, R. J, SHEN, Y. R, LEE, Y. T

Volltext

Spironolactone in Patients with Heart Failure von Fernandez, Helen M, Leipzig, Rosanne M, Larkin, Robert J, Atlas, Stephen A, Donohue, Thomas J, Vanpee, Dominique, Swine, Christian, Glick, Gerald, Pitt, Bertram, Perez, Alfonso

Volltext

Intensity of the sulfur dioxide rotational spectrum von Larkin, Robert J., Lovejoy, Roland W., Silvaggio, Peter M., Boese, Robert W.

Volltext

Frequency tripling into the 720–1025‐Å region with pulsed free jets von Page, Ralph H., Larkin, Robert J., Kung, A. H., Shen, Y. R., Lee, Y. T.

Volltext

NMS with multi-server change requests processing von LARKIN JAMES, GUNTHER BRIAN, LARKIN ROBERT J, HOLIERHOEK HUBERT

Volltext bestellen

Erratum: Frequency tripling into the 720–1025‐Å region with pulsed free jets [Rev. Sci. Instrum. 5 8, 1616 (1987)] von Page, Ralph H., Larkin, Robert J., Kung, A. H., Shen, Y. R., Lee, Y. T.

Volltext

A Comparison of Audio, Visual, and Tactile Warning Devices in a Simulated Flight Environment von Larkin, Robert J

Volltext bestellen

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up von Haanen, J., Obeid, M., Spain, L., Carbonnel, F., Wang, Y., Robert, C., Lyon, A.R., Wick, W., Kostine, M., Peters, S., Jordan, K., Larkin, J.

Volltext

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Haanen, J.B.A.G., Carbonnel, F., Robert, C., Kerr, K.M., Peters, S., Larkin, J., Jordan, K.

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind st... von Long, Georgina V, Prof, Dummer, Reinhard, Prof, Hamid, Omid, MD, Gajewski, Thomas F, Prof, Caglevic, Christian, MD, Dalle, Stephane, Prof, Arance, Ana, MD, Carlino, Matteo S, PhD, Grob, Jean-Jacques, Prof, Kim, Tae Min, Prof, Demidov, Lev, Prof, Robert, Caroline, Prof, Larkin, James, Prof, Anderson, James R, PhD, Maleski, Janet, BSN, Jones, Mark, MD, Diede, Scott J, MD, Mitchell, Tara C, MD

Volltext

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study von Long, G.V., Flaherty, K.T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J.B.A.G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M.A., Lane, S.R., Legos, J.J., Mookerjee, B., Grob, J.-J.

Volltext

Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes von Nathan, David M, Lachin, John M, Balasubramanyam, Ashok, Burch, Henry B, Buse, John B, Butera, Nicole M, Cohen, Robert M, Crandall, Jill P, Kahn, Steven E, Krause-Steinrauf, Heidi, Larkin, Mary E, Rasouli, Neda, Tiktin, Margaret, Wexler, Deborah J, Younes, Naji

Volltext

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Haanen, J B A G, Carbonnel, F, Robert, C, Kerr, K M, Peters, S, Larkin, J, Jordan, K

Volltext

Metabolic engineering of biomass for high energy density: oilseed‐like triacylglycerol yields from plant leaves von Vanhercke, Thomas, El Tahchy, Anna, Liu, Qing, Zhou, Xue‐Rong, Shrestha, Pushkar, Divi, Uday K, Ral, Jean‐Philippe, Mansour, Maged P, Nichols, Peter D, James, Christopher N, Horn, Patrick J, Chapman, Kent D, Beaudoin, Frederic, Ruiz‐López, Noemi, Larkin, Philip J, Feyter, Robert C, Singh, Surinder P, Petrie, James R

Volltext

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial von Motzer, Robert J., Robbins, Paul B., Powles, Thomas, Albiges, Laurence, Haanen, John B., Larkin, James, Mu, Xinmeng Jasmine, Ching, Keith A., Uemura, Motohide, Pal, Sumanta K., Alekseev, Boris, Gravis, Gwenaelle, Campbell, Matthew T., Penkov, Konstantin, Lee, Jae Lyun, Hariharan, Subramanian, Wang, Xiao, Zhang, Weidong, Wang, Jing, Chudnovsky, Aleksander, di Pietro, Alessandra, Donahue, Amber C., Choueiri, Toni K.

Volltext

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma von Long, Georgina V, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Schadendorf, Dirk, Lesimple, Thierry, Plummer, Ruth, Ji, Ran, Zhang, Pingkuan, Mookerjee, Bijoyesh, Legos, Jeff, Kefford, Richard, Dummer, Reinhard, Kirkwood, John M

Volltext

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma von Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee

Volltext

Low input pilot burner von JR. ROBERT B. LARKIN

Volltext bestellen

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial... von Motzer, Robert J., Escudier, Bernard, George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Plimack, Elizabeth R., Procopio, Giuseppe, McDermott, David F., Castellano, Daniel, Choueiri, Toni K., Donskov, Frede, Gurney, Howard, Oudard, Stéphane, Richardet, Martin, Peltola, Katriina, Alva, Ajjai S., Carducci, Michael, Wagstaff, John, Chevreau, Christine, Fukasawa, Satoshi, Tomita, Yoshihiko, Gauler, Thomas C., Kollmannsberger, Christian K., Schutz, Fabio A., Larkin, James, Cella, David, McHenry, M. Brent, Saggi, Shruti Shally, Tannir, Nizar M.

Volltext